Clinical Trial Update: Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating single-dose pharmacokinetics of oral testosterone undecanoate with and without UGT2B17 inhibition in hypogonadism, male (Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism Male

Drugs mentioned

• testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: University of Washington | Conditions: Hypogonadism, Male | Phase 1, Phase 2 | Status: UNKNOWN